Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab.

Sci Rep · 2025 · PMC12328655 · PMID 40770215

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The nab-PTX plus RAM group showed a trend toward increased neutropenia and febrile neutropenia; however, no other differences were observed.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.